SALT for Patients With Hepatic Cirrhosis

计划入组 47 人 · 首次发布于 2023 年 12 月 1 日

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

计划入组 20 人 · 首次发布于 2016 年 1 月 11 日

Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis

计划入组 100 人 · 首次发布于 2012 年 10 月 24 日

Chlorothiazide(Diuril)

C₇H₆ClN₃O₄S₂

Chlorthalidone(Edarbyclor, Tenoretic, Thalitone)

C₁₄H₁₁ClN₂O₄S · Rx

Hepatic Carcinoma Vaccine(WestGene)

Calliditas Therapeutics

Sweden

Axcella Health

United States

Chengdu Kanghong Pharmaceutical Group Co., Ltd

China

Bausch Health's Phase 3 RED-C Trials for Hepatic Encephalopathy Prevention Fail to Meet Primary Endpoint

Bausch Health's Xifaxan Successor Fails Phase III Trials for Hepatic Encephalopathy Prevention

Korro Bio's KRRO-110 Receives Green Light in Australia for AATD Trial